BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing
Go back to BioNxt Solutions Announces Completion of Cladribine ODF Toxicity Study and Financing| (AMEX: BNXTF) | Delayed: 0.24 +0.01 (4.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.23 | 52 Week High | $ | |||
| Open | $0.24 | 52 Week Low | $ | |||
| Day High | $0.24 | P/E | N/A | |||
| Day Low | $0.24 | EPS | $ | |||
| Volume | 132 | |||||
